• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铁过载疾病。

Iron overload disorders.

机构信息

Medstar Georgetown University HospitalMedstar Georgetown Transplant InstituteWashingtonDistrict of ColumbiaUSA.

Gastroenterology and HepatologyUniversity of New MexicoAlbuquerqueNew MexicoUSA.

出版信息

Hepatol Commun. 2022 Aug;6(8):1842-1854. doi: 10.1002/hep4.2012. Epub 2022 Jun 14.

DOI:10.1002/hep4.2012
PMID:35699322
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9315134/
Abstract

Iron overload disorders represent a variety of conditions that lead to increased total body iron stores and resultant end-organ damage. An elevated ferritin and transferrin-iron saturation can be commonly encountered in the evaluation of elevated liver enzymes. Confirmatory homeostatic iron regulator (HFE) genetic testing for C282Y and H63D, mutations most encountered in hereditary hemochromatosis, should be pursued in evaluation of hyperferritinemia. Magnetic resonance imaging with quantitative assessment of iron content or liver biopsy (especially if liver disease is a cause of iron overload) should be used as appropriate. A secondary cause for iron overload should be considered if HFE genetic testing is negative for the C282Y homozygous or C282Y/H63D compound heterozygous mutations. Differential diagnosis of secondary iron overload includes hematologic disorders, iatrogenic causes, or chronic liver diseases. More common hematologic disorders include thalassemia syndromes, myelodysplastic syndrome, myelofibrosis, sideroblastic anemias, sickle cell disease, or pyruvate kinase deficiency. If iron overload has been excluded, evaluation for causes of hyperferritinemia should be pursued. Causes of hyperferritinemia include chronic liver disease, malignancy, infections, kidney failure, and rheumatic conditions, such as adult-onset Still's disease or hemophagocytic lymphohistiocytosis. In this review, we describe the diagnostic testing of patients with suspected hereditary hemochromatosis, the evaluation of patients with elevated serum ferritin levels, and signs of secondary overload and treatment options for those with secondary iron overload.

摘要

铁过载疾病表现为多种导致体内铁总量增加并由此引发靶器官损伤的病症。在评估肝酶升高时,通常会遇到升高的铁蛋白和转铁蛋白铁饱和度。在评估高血铁蛋白症时,应进行常见于遗传性血色素沉着症的铁调素(HFE)基因 C282Y 和 H63D 突变的确认性内稳态调节因子(HFE)基因检测。如果 HFE 基因检测对 C282Y 纯合子或 C282Y/H63D 复合杂合突变呈阴性,应考虑铁过载的继发原因。如果排除铁过载,应进一步评估高血铁蛋白症的病因。高血铁蛋白症的病因包括慢性肝病、医源性原因或慢性肝脏疾病。更常见的血液系统疾病包括地中海贫血综合征、骨髓增生异常综合征、骨髓纤维化、铁幼粒细胞性贫血、镰状细胞病或丙酮酸激酶缺乏症。如果已经排除铁过载,则应进一步评估高血铁蛋白症的病因。高血铁蛋白症的病因包括慢性肝病、恶性肿瘤、感染、肾衰竭和风湿性疾病,如成人Still 病或噬血细胞性淋巴组织细胞增多症。在本综述中,我们描述了疑似遗传性血色素沉着症患者的诊断性检测、血清铁蛋白水平升高患者的评估以及继发过载的迹象和继发铁过载的治疗选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8075/9315134/742cb634fbcf/HEP4-6-1842-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8075/9315134/f95e37fd991b/HEP4-6-1842-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8075/9315134/742cb634fbcf/HEP4-6-1842-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8075/9315134/f95e37fd991b/HEP4-6-1842-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8075/9315134/742cb634fbcf/HEP4-6-1842-g001.jpg

相似文献

1
Iron overload disorders.铁过载疾病。
Hepatol Commun. 2022 Aug;6(8):1842-1854. doi: 10.1002/hep4.2012. Epub 2022 Jun 14.
2
HFE mutations in Caucasian participants of the Hemochromatosis and Iron Overload Screening study with serum ferritin level <1000 µg/L.血色素沉着症和铁过载筛查研究中血清铁蛋白水平<1000µg/L的白种人参与者中的HFE突变。
Can J Gastroenterol. 2013 Jul;27(7):390-2. doi: 10.1155/2013/493170.
3
Magnetic Resonance Liver Iron Concentration Can Guide Venesection Decision-Making in Hyperferritinemia.磁共振肝脏铁浓度可指导高铁蛋白血症患者的放血决策。
Dig Dis Sci. 2023 Jun;68(6):2704-2709. doi: 10.1007/s10620-023-07873-w. Epub 2023 Mar 17.
4
Hereditary hemochromatosis in a Brazilian university hospital in São Paulo State (1990-2000).圣保罗州一家巴西大学医院的遗传性血色素沉着症(1990 - 2000年)
Genet Mol Res. 2005 Mar 31;4(1):31-8.
5
[Molecular genetic diagnostics and screening of hereditary hemochromatosis].[遗传性血色素沉着症的分子遗传学诊断与筛查]
Vnitr Lek. 2006 Jun;52(6):602-8.
6
Hereditary hemochromatosis: missed diagnosis or misdiagnosis?遗传性血色素沉着症:漏诊还是误诊?
Am J Med. 2013 Nov;126(11):1010-5. doi: 10.1016/j.amjmed.2013.07.013. Epub 2013 Sep 18.
7
Iron-overload and genotypic expression of HFE mutations H63D/C282Y and transferrin receptor Hin6I and BanI polymorphism in german patients with hereditary haemochromatosis.德国遗传性血色素沉着症患者的铁过载、HFE 突变 H63D/C282Y 的基因型表达以及转铁蛋白受体 Hin6I 和 BanI 多态性
Eur J Immunogenet. 2000 Jun;27(3):129-34. doi: 10.1046/j.1365-2370.2000.00215.x.
8
Hepatic iron overload: direct HFE (HLA-H) mutation analysis vs quantitative iron assays for the diagnosis of hereditary hemochromatosis.肝铁过载:用于遗传性血色素沉着症诊断的直接HFE(HLA-H)突变分析与定量铁测定法
Am J Clin Pathol. 1998 May;109(5):577-84. doi: 10.1093/ajcp/109.5.577.
9
Hemochromatosis and iron-overload screening in a racially diverse population.不同种族人群中的血色素沉着症和铁过载筛查
N Engl J Med. 2005 Apr 28;352(17):1769-78. doi: 10.1056/NEJMoa041534.
10
Predicting iron overload in hyperferritinemia.预测高铁蛋白血症中的铁过载。
Clin Gastroenterol Hepatol. 2009 Mar;7(3):359-62. doi: 10.1016/j.cgh.2008.11.010. Epub 2008 Nov 21.

引用本文的文献

1
Leptomeningeal Carcinomatosis and Myelophthisic Anemia as Initial Manifestations of Metastatic Lobular Breast Cancer.柔脑膜癌病和骨髓痨性贫血作为转移性小叶乳腺癌的初始表现
Case Rep Oncol Med. 2025 Aug 26;2025:5631996. doi: 10.1155/crom/5631996. eCollection 2025.
2
DNA methylation in adaptation to high-altitude environments and pathogenesis of related diseases.DNA甲基化在适应高海拔环境及相关疾病发病机制中的作用
Hum Genomics. 2025 Aug 30;19(1):100. doi: 10.1186/s40246-025-00794-x.
3
Focal iron sparing mimicking liver lesion in post-transfusion iron overload: A case report.

本文引用的文献

1
Characterization and prognosis of temozolomide-induced aplastic anemia in patients with central nervous system malignancies.替莫唑胺致中枢神经系统恶性肿瘤患者再生障碍性贫血的特征及预后。
Neuro Oncol. 2022 Jun 1;24(6):964-973. doi: 10.1093/neuonc/noab240.
2
Hematologic complications of immune checkpoint inhibitors.免疫检查点抑制剂的血液学并发症。
Blood. 2022 Jun 23;139(25):3594-3604. doi: 10.1182/blood.2020009016.
3
Recommendations on hematopoietic stem cell transplantation for patients with Diamond-Blackfan anemia. On behalf of the Pediatric Diseases and Severe Aplastic Anemia Working Parties of the EBMT.
输血后铁过载中类似肝脏病变的局灶性铁保留:一例报告
Radiol Case Rep. 2025 Aug 9;20(11):5478-5483. doi: 10.1016/j.radcr.2025.07.024. eCollection 2025 Nov.
4
Multimodal imaging features to diagnose abdominal complications of sickle cell disease.用于诊断镰状细胞病腹部并发症的多模态成像特征。
Abdom Radiol (NY). 2025 Jun 30. doi: 10.1007/s00261-025-05083-8.
5
FRRS1L variants and ferriheme overload drive hyperpigmentation and systemic Iron overload in lanping black bone sheep.FRRS1L基因变异和高铁血红素过载导致兰坪乌骨羊色素沉着过度和全身性铁过载。
Cell Biosci. 2025 Jun 24;15(1):87. doi: 10.1186/s13578-025-01426-6.
6
Assessment of the distribution of pancreatic iron deposition in non-transfusion dependent thalassemia.非输血依赖型地中海贫血患者胰腺铁沉积分布的评估
Abdom Radiol (NY). 2025 Jun 23. doi: 10.1007/s00261-025-04995-9.
7
A dedicated phantom for exploring the interplay of fat and paramagnetic substances in quantitative susceptibility mapping.一种用于在定量磁化率成像中探究脂肪和顺磁性物质相互作用的专用体模。
MAGMA. 2025 Jun 2. doi: 10.1007/s10334-025-01261-3.
8
Lactoferrin-A Regulator of Iron Homeostasis and Its Implications in Cancer.乳铁蛋白——铁稳态的调节因子及其在癌症中的意义
Molecules. 2025 Mar 28;30(7):1507. doi: 10.3390/molecules30071507.
9
Multi-Center, Multi-Vendor Validation of Simultaneous MRI-Based Proton Density Fat Fraction and R2* Mapping Using a Combined Proton Density Fat Fraction-R2* Phantom.使用联合质子密度脂肪分数-R2*体模对基于MRI的同步质子密度脂肪分数和R2*成像进行多中心、多供应商验证
J Magn Reson Imaging. 2025 Apr 18. doi: 10.1002/jmri.29775.
10
Cutting edge: ferroptosis in metabolic dysfunction-associated steatotic liver disease (MASLD) pathogenesis and therapy.前沿:铁死亡在代谢功能障碍相关脂肪性肝病(MASLD)发病机制及治疗中的作用
Funct Integr Genomics. 2025 Mar 25;25(1):71. doi: 10.1007/s10142-025-01579-0.
DBA 患者造血干细胞移植的推荐意见。代表 EBMT 的儿科疾病和重型再生障碍性贫血工作组。
Bone Marrow Transplant. 2021 Dec;56(12):2956-2963. doi: 10.1038/s41409-021-01449-w. Epub 2021 Aug 31.
4
The serum ferritin levels and liver iron concentrations in patients with alphathalassemia is there a good correlation?地中海贫血患者的血清铁蛋白水平与肝铁浓度之间是否存在良好的相关性?
Hematology. 2021 Dec;26(1):473-477. doi: 10.1080/16078454.2021.1943829.
5
Hepatocellular carcinoma in patients with thalassemia in the post-DAA era: not a disappearing entity.直接抗病毒药物(DAA)时代后地中海贫血患者中的肝细胞癌:并非一个正在消失的实体。
Ann Hematol. 2021 Jul;100(7):1907-1910. doi: 10.1007/s00277-021-04511-1. Epub 2021 Apr 13.
6
The Clinical Significance of Iron Overload and Iron Metabolism in Myelodysplastic Syndrome and Acute Myeloid Leukemia.骨髓增生异常综合征和急性髓系白血病中铁过载和铁代谢的临床意义。
Front Immunol. 2021 Feb 19;11:627662. doi: 10.3389/fimmu.2020.627662. eCollection 2020.
7
Therapy for lower-risk MDS.低危 MDS 的治疗。
Hematology Am Soc Hematol Educ Program. 2020 Dec 4;2020(1):426-433. doi: 10.1182/hematology.2020000127.
8
Massive iron overload and acute-on-chronic liver failure in a patient with Diamond-Blackfan anaemia: a case report.一名患有先天性纯红细胞再生障碍性贫血的患者出现大量铁过载及慢加急性肝衰竭:病例报告
BMC Gastroenterol. 2020 Oct 12;20(1):332. doi: 10.1186/s12876-020-01468-9.
9
Iron Chelation in Transfusion-Dependent Patients With Low- to Intermediate-1-Risk Myelodysplastic Syndromes.低至中危1型骨髓增生异常综合征输血依赖患者的铁螯合治疗
Ann Intern Med. 2020 Oct 6;173(7):595-596. doi: 10.7326/L20-1056.
10
Toxic iron species in lower-risk myelodysplastic syndrome patients: course of disease and effects on outcome.低危骨髓增生异常综合征患者中的毒性铁物种:疾病进程及对预后的影响。
Leukemia. 2021 Jun;35(6):1745-1750. doi: 10.1038/s41375-020-01022-2. Epub 2020 Sep 18.